Furthermore, it addresses the FDA’s communications With all the applicant, the retention of information that assist the SE report, confidentiality of an SE report, how an applicant can amend or withdraw an SE report, how an applicant may perhaps transfer possession of the SE report back to a new applicant and electronic submission on the SE repor